布洛芬缓释胶囊与穴位埋线联合治疗对原发性痛经患者近期疗效与痛经积分的影响

Effect of ibuprofen sustained-release capsule combined with catgut embedding in acupoints on short-term efficacy and dysmenorrhea score in primary dysmenorrhea patients

  • 摘要: 目的 探讨布洛芬缓释胶囊与穴位埋线联合治疗对原发性痛经患者近期疗效与痛经积分的影响。 方法 选取本院收治的原发性痛经患者60例,采用电脑随机分组法分为2组,每组30例。对照组采用布洛芬缓释胶囊治疗,观察组采用布洛芬缓释胶囊与穴位埋线联合治疗,比较2组治疗前后痛经积分、疼痛情况和近期疗效。 结果 治疗前,2组痛经积分、疼痛评分比较,差异无统计学意义(P>0.05); 治疗后,观察组痛经积分、疼痛评分低于对照组,差异有统计学意义(P<0.05); 观察组治疗总有效率为90.00%, 高于对照组的66.67%, 差异有统计学意义(P<0.05)。 结论 布洛芬缓释胶囊与穴位埋线联合治疗原发性痛经能够明显缓解患者的疼痛情况,降低痛经积分,提升近期疗效。

     

    Abstract: Objective To investigate the effect of ibuprofen sustained-release capsule combined with catgut embedding in acupoints on the short-term efficacy and dysmenorrhea score in primary dysmenorrhea patients. Methods A total of 60 patients with primary dysmenorrhea treated in our hospital were divided into two groups according to computer random grouping method. The control group(n=30)was treated with ibuprofen sustained-release capsule, while the observation group(n=30)was treated with ibuprofen sustained-release capsule and catgut embedding in acupoints, and the score of dysmenorrhea, pain and short-term efficacy before and after treatment were compared between the two groups. Results There were no significant differences in the dysmenorrhea score and pain score between the observation group and the control group before treatment(P>0.05). The dysmenorrhea score and pain score of the observation group after treatment were significantly lower than those of the control group(P<0.05). The total effectiverate of the observation group was significantly higher than that of the control group(90.00% versus 66.67%, P<0.05). Conclusion The buprofen sustain-release capsule combined with catgut embedding in acupoints can significantly improve patients' pain, reduce the dysmenorrhea score, and improve the short-term efficacy.

     

/

返回文章
返回